Clinical Trial: Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating Pharmacokinetics and Safety of a Human Monoclonal Antibody (AVP-21D9) in Normal Healthy Volunteers

Brief Summary:

Primary:

• To compare the safety profile of a single intravenous administration of AVP-21D9 as compared with Placebo

Secondary:

  • To evaluate the pharmacokinetics (PK) of a single intravenous administration of AVP-21D9
  • To evaluate the immunogenicity of AVP-21D9